Cash flow Aier Eye Hospital Group Co., Ltd.
Equities
300015
CNE100000GR6
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.330 CNY | -2.10% | +0.21% | -41.02% |
08-26 | Citi Downgrades Aier Eye Hospital Group to Sell From Neutral; Price Target is 7 Yuan | MT |
08-26 | Aier Eye Hospital Group H1 Profit Up 20%, Operating Income Rises 3% | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.38B | 1.72B | 2.32B | 2.52B | 3.36B | |||||
Depreciation & Amortization - CF | 342M | 399M | 934M | 1.13B | 1.32B | |||||
Amortization of Goodwill and Intangible Assets - (CF) | 282K | 282K | 3.07M | 21.17M | 9.94M | |||||
Depreciation & Amortization, Total | 342M | 399M | 938M | 1.15B | 1.33B | |||||
Amortization of Deferred Charges, Total - (CF) | 162M | 151M | 187M | 240M | 339M | |||||
(Gain) Loss From Sale Of Asset | 974K | -934K | -52.45K | 1.25M | -711K | |||||
(Gain) Loss on Sale of Investments - (CF) | -84.09M | 211M | 344M | 315M | 32.9M | |||||
Asset Writedown & Restructuring Costs | 318M | 366M | 221M | 100M | 390M | |||||
Provision and Write-off of Bad Debts | 68.38M | 90.53M | 97.89M | 77.27M | 107M | |||||
Other Operating Activities, Total | 137M | 265M | 234M | 204M | 443M | |||||
Change In Accounts Receivable | -272M | -132M | -109M | -68.21M | -265M | |||||
Change In Inventories | 8.98M | -38.91M | -37.58M | -159M | -169M | |||||
Change In Accounts Payable | 17.86M | 342M | -207M | -48.99M | 136M | |||||
Change In Deferred Taxes | -2.23M | -34.22M | -33.76M | -73.7M | 26.6M | |||||
Change in Other Net Operating Assets | 2.93M | 972K | 127M | 228M | 145M | |||||
Cash from Operations | 2.08B | 3.34B | 4.08B | 4.49B | 5.87B | |||||
Capital Expenditure | -746M | -894M | -1.49B | -1.39B | -1.46B | |||||
Sale of Property, Plant, and Equipment | 5.94M | 5.44M | 6.37M | 7.81M | 5.55M | |||||
Cash Acquisitions | -957M | -30.05M | -946M | -1.13B | -1.59B | |||||
Divestitures | - | - | - | 180K | - | |||||
Investment in Marketable and Equity Securities, Total | -159M | -317M | -250M | -796M | -306M | |||||
Other Investing Activities, Total | 96.44M | 178M | 169M | 42.4M | 41.75M | |||||
Cash from Investing | -1.76B | -1.06B | -2.51B | -3.26B | -3.3B | |||||
Long-Term Debt Issued, Total | 2.85B | 2.61B | 720M | 438M | 863M | |||||
Total Debt Issued | 2.85B | 2.61B | 720M | 438M | 863M | |||||
Long-Term Debt Repaid, Total | -2.05B | -3.04B | -1.17B | -2.35B | -1.42B | |||||
Total Debt Repaid | -2.05B | -3.04B | -1.17B | -2.35B | -1.42B | |||||
Issuance of Common Stock | - | 693M | 1.3B | 3.85B | - | |||||
Repurchase of Common Stock | - | - | -3.18M | -5.1M | -576M | |||||
Common Dividends Paid | -514M | -531M | -663M | -673M | -747M | |||||
Common & Preferred Stock Dividends Paid | -514M | -531M | -663M | -673M | -747M | |||||
Other Financing Activities, Total | -119M | -580M | -420M | -873M | -628M | |||||
Cash from Financing | 164M | -852M | -240M | 390M | -2.51B | |||||
Foreign Exchange Rate Adjustments | 4.13M | -9.92M | 10.39M | 21.71M | 34.84M | |||||
Net Change in Cash | 488M | 1.42B | 1.34B | 1.64B | 92.57M | |||||
Supplemental Items | ||||||||||
Cash Interest Paid | - | - | - | - | - | |||||
Cash Income Tax Paid (Refund) | 566M | 616M | 1.06B | 1.05B | 1.17B | |||||
Levered Free Cash Flow | 1.57B | 1.92B | 3.05B | 2.61B | 3.11B | |||||
Unlevered Free Cash Flow | 1.61B | 1.97B | 3.15B | 2.72B | 3.23B | |||||
Change In Net Working Capital | -393M | -252M | -877M | -61.82M | 387M | |||||
Net Debt Issued / Repaid | 798M | -434M | -450M | -1.91B | -559M |